HEADER SUGAR BINDING PROTEIN 30-APR-08 3D02 TITLE CRYSTAL STRUCTURE OF PERIPLASMIC SUGAR-BINDING PROTEIN TITLE 2 (YP_001338366.1) FROM KLEBSIELLA PNEUMONIAE SUBSP. PNEUMONIAE MGH TITLE 3 78578 AT 1.30 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE LACI-TYPE TRANSCRIPTIONAL REGULATOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE SUBSP. PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 272620; SOURCE 4 STRAIN: STRAIN ATCC 700721 / MGH 78578; SOURCE 5 GENE: YP_001338366.1, KPN78578_46750, KPN_04753; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_001338366.1, PERIPLASMIC SUGAR-BINDING PROTEIN, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, TRANSCRIPTION, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3D02 1 REMARK SEQADV REVDAT 5 24-JUL-19 3D02 1 REMARK LINK REVDAT 4 25-OCT-17 3D02 1 REMARK REVDAT 3 13-JUL-11 3D02 1 VERSN REVDAT 2 24-FEB-09 3D02 1 VERSN REVDAT 1 27-MAY-08 3D02 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PERIPLASMIC SUGAR-BINDING PROTEIN JRNL TITL 2 (YP_001338366.1) FROM KLEBSIELLA PNEUMONIAE SUBSP. JRNL TITL 3 PNEUMONIAE MGH 78578 AT 1.30 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 70928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.172 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3596 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.34 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4655 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.49 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 245 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2263 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 313 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.26000 REMARK 3 B22 (A**2) : 0.05000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.048 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.048 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.031 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.727 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.966 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2680 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1778 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3684 ; 1.767 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4391 ; 1.009 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 373 ; 5.597 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 110 ;39.325 ;25.273 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 464 ;11.254 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;14.926 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 411 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3176 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 510 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1730 ; 1.412 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 689 ; 0.411 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2842 ; 2.325 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 950 ; 4.001 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 842 ; 5.926 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 3.CHLORIDE IONS FROM CRYSTALLIZATION AND GLYCEROL MOLECULE REMARK 3 FROM CRYO CONDITION ARE MODELED IN THE STRUCTURE. REMARK 4 REMARK 4 3D02 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047421. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91162,0.97932,0.97918 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70966 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 28.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.00M LICL, 30.00% PEG-6000, 0.1M REMARK 280 CITRATE PH 4.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.99000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.99000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.12000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 38.48000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.12000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 38.48000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.99000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.12000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 38.48000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.99000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.12000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 38.48000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHOR STATE THAT THE RESULTS FROM SIZE EXCLUSION REMARK 300 CHROMATOGRAPHY SUPPORT THE ASSIGNMENT OF A MONOMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 25 REMARK 465 ALA A 26 REMARK 465 ALA A 27 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 76 CE NZ REMARK 470 LYS A 104 CE NZ REMARK 470 LYS A 146 CE NZ REMARK 470 LYS A 151 CD CE NZ REMARK 470 LYS A 175 NZ REMARK 470 ARG A 236 NE CZ NH1 NH2 REMARK 470 LYS A 240 CD CE NZ REMARK 470 LYS A 287 CE NZ REMARK 470 GLU A 290 CD OE1 OE2 REMARK 470 GLU A 294 CG CD OE1 OE2 REMARK 470 LYS A 296 CG CD CE NZ REMARK 470 GLU A 297 CD OE1 OE2 REMARK 470 LYS A 300 CG CD CE NZ REMARK 470 LYS A 307 CE NZ REMARK 470 LYS A 314 CE NZ REMARK 470 ASP A 321 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 117 OH TYR A 267 2.06 REMARK 500 OE2 GLU A 28 ND2 ASN A 58 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 38 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 118 59.41 -150.09 REMARK 500 SER A 118 59.41 -140.55 REMARK 500 THR A 266 -159.59 -156.18 REMARK 500 LEU A 326 -141.65 -107.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390056 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. THE CLONED REMARK 999 CONSTRUCT CONTAINS RESIDUES 26-327 OF THE FULL LENGTH PROTEIN. DBREF 3D02 A 26 327 UNP A6THR5 A6THR5_KLEP7 26 327 SEQADV 3D02 GLY A 25 UNP A6THR5 EXPRESSION TAG SEQRES 1 A 303 GLY ALA ALA GLU LYS THR VAL VAL ASN ILE SER LYS VAL SEQRES 2 A 303 ASP GLY MSE PRO TRP PHE ASN ARG MSE GLY GLU GLY VAL SEQRES 3 A 303 VAL GLN ALA GLY LYS GLU PHE ASN LEU ASN ALA SER GLN SEQRES 4 A 303 VAL GLY PRO SER SER THR ASP ALA PRO GLN GLN VAL LYS SEQRES 5 A 303 ILE ILE GLU ASP LEU ILE ALA ARG LYS VAL ASP ALA ILE SEQRES 6 A 303 THR ILE VAL PRO ASN ASP ALA ASN VAL LEU GLU PRO VAL SEQRES 7 A 303 PHE LYS LYS ALA ARG ASP ALA GLY ILE VAL VAL LEU THR SEQRES 8 A 303 ASN GLU SER PRO GLY GLN PRO SER ALA ASN TRP ASP VAL SEQRES 9 A 303 GLU ILE ILE ASP ASN GLU LYS PHE ALA ALA GLU TYR VAL SEQRES 10 A 303 GLU HIS MSE ALA LYS ARG MSE GLY GLY LYS GLY GLY TYR SEQRES 11 A 303 VAL ILE TYR VAL GLY SER LEU THR VAL PRO GLN HIS ASN SEQRES 12 A 303 LEU TRP ALA ASP LEU LEU VAL LYS TYR GLN LYS GLU HIS SEQRES 13 A 303 TYR PRO ASP MSE HIS GLU VAL THR ARG ARG MSE PRO VAL SEQRES 14 A 303 ALA GLU SER VAL ASP ASP SER ARG ARG THR THR LEU ASP SEQRES 15 A 303 LEU MSE LYS THR TYR PRO ASP LEU LYS ALA VAL VAL SER SEQRES 16 A 303 PHE GLY SER ASN GLY PRO ILE GLY ALA GLY ARG ALA VAL SEQRES 17 A 303 LYS GLU LYS ARG ALA LYS ASN LYS VAL ALA VAL TYR GLY SEQRES 18 A 303 MSE MSE ILE PRO SER GLN ALA ALA SER LEU ILE LYS SER SEQRES 19 A 303 GLY ASP ILE THR GLU GLY ILE THR TYR ASP PRO ALA THR SEQRES 20 A 303 ALA GLY TYR ALA LEU ALA ALA VAL ALA SER THR LEU LEU SEQRES 21 A 303 ASN GLY LYS THR ILE GLU PRO GLY PHE GLU LEU LYS GLU SEQRES 22 A 303 LEU GLY LYS ALA GLU VAL ASP SER ASP LYS HIS ILE ILE SEQRES 23 A 303 ARG PHE HIS LYS VAL LEU LEU VAL ASN LYS ASP ASN ILE SEQRES 24 A 303 ASP SER LEU TYR MODRES 3D02 MSE A 40 MET SELENOMETHIONINE MODRES 3D02 MSE A 46 MET SELENOMETHIONINE MODRES 3D02 MSE A 144 MET SELENOMETHIONINE MODRES 3D02 MSE A 148 MET SELENOMETHIONINE MODRES 3D02 MSE A 184 MET SELENOMETHIONINE MODRES 3D02 MSE A 191 MET SELENOMETHIONINE MODRES 3D02 MSE A 208 MET SELENOMETHIONINE MODRES 3D02 MSE A 246 MET SELENOMETHIONINE MODRES 3D02 MSE A 247 MET SELENOMETHIONINE HET MSE A 40 16 HET MSE A 46 16 HET MSE A 144 16 HET MSE A 148 16 HET MSE A 184 8 HET MSE A 191 16 HET MSE A 208 8 HET MSE A 246 8 HET MSE A 247 8 HET CL A 1 1 HET CL A 2 1 HET CL A 3 1 HET GOL A 4 12 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 9(C5 H11 N O2 SE) FORMUL 2 CL 3(CL 1-) FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *313(H2 O) HELIX 1 1 MSE A 40 PHE A 57 1 18 HELIX 2 2 ASP A 70 ARG A 84 1 15 HELIX 3 3 ASP A 95 ALA A 109 1 15 HELIX 4 4 ASP A 132 MSE A 148 1 17 HELIX 5 5 VAL A 163 TYR A 181 1 19 HELIX 6 6 SER A 196 TYR A 211 1 16 HELIX 7 7 ASN A 223 LYS A 235 1 13 HELIX 8 8 ILE A 248 SER A 258 1 11 HELIX 9 9 ASP A 268 ASN A 285 1 18 HELIX 10 10 ASN A 322 LEU A 326 5 5 SHEET 1 A 7 LEU A 59 VAL A 64 0 SHEET 2 A 7 LYS A 29 ILE A 34 1 N LYS A 29 O ASN A 60 SHEET 3 A 7 ALA A 88 ILE A 91 1 O THR A 90 N VAL A 32 SHEET 4 A 7 VAL A 112 ASN A 116 1 O VAL A 112 N ILE A 89 SHEET 5 A 7 TRP A 126 GLU A 129 1 O VAL A 128 N THR A 115 SHEET 6 A 7 ILE A 309 ARG A 311 1 O ILE A 310 N ASP A 127 SHEET 7 A 7 GLU A 302 ASP A 304 -1 N GLU A 302 O ARG A 311 SHEET 1 B 6 MSE A 184 GLU A 186 0 SHEET 2 B 6 GLY A 152 TYR A 157 1 N TYR A 154 O HIS A 185 SHEET 3 B 6 LEU A 214 SER A 219 1 O LYS A 215 N GLY A 153 SHEET 4 B 6 ALA A 242 GLY A 245 1 O TYR A 244 N VAL A 217 SHEET 5 B 6 GLU A 263 THR A 266 1 O ILE A 265 N GLY A 245 SHEET 6 B 6 LEU A 316 VAL A 318 -1 O LEU A 316 N THR A 266 SHEET 1 C 2 GLU A 294 LEU A 295 0 SHEET 2 C 2 GLY A 299 LYS A 300 -1 O GLY A 299 N LEU A 295 LINK C GLY A 39 N AMSE A 40 1555 1555 1.33 LINK C GLY A 39 N BMSE A 40 1555 1555 1.34 LINK C AMSE A 40 N PRO A 41 1555 1555 1.33 LINK C BMSE A 40 N PRO A 41 1555 1555 1.34 LINK C ARG A 45 N AMSE A 46 1555 1555 1.33 LINK C ARG A 45 N BMSE A 46 1555 1555 1.33 LINK C AMSE A 46 N GLY A 47 1555 1555 1.32 LINK C BMSE A 46 N GLY A 47 1555 1555 1.33 LINK C HIS A 143 N AMSE A 144 1555 1555 1.33 LINK C HIS A 143 N BMSE A 144 1555 1555 1.33 LINK C AMSE A 144 N ALA A 145 1555 1555 1.32 LINK C BMSE A 144 N ALA A 145 1555 1555 1.33 LINK C ARG A 147 N AMSE A 148 1555 1555 1.32 LINK C ARG A 147 N BMSE A 148 1555 1555 1.33 LINK C AMSE A 148 N GLY A 149 1555 1555 1.31 LINK C BMSE A 148 N GLY A 149 1555 1555 1.35 LINK C ASP A 183 N MSE A 184 1555 1555 1.32 LINK C MSE A 184 N HIS A 185 1555 1555 1.33 LINK C ARG A 190 N AMSE A 191 1555 1555 1.32 LINK C ARG A 190 N BMSE A 191 1555 1555 1.32 LINK C AMSE A 191 N PRO A 192 1555 1555 1.34 LINK C BMSE A 191 N PRO A 192 1555 1555 1.34 LINK C LEU A 207 N MSE A 208 1555 1555 1.33 LINK C MSE A 208 N LYS A 209 1555 1555 1.32 LINK C GLY A 245 N MSE A 246 1555 1555 1.31 LINK C MSE A 246 N MSE A 247 1555 1555 1.32 LINK C MSE A 247 N ILE A 248 1555 1555 1.33 SITE 1 AC1 5 SER A 35 PHE A 43 GLN A 63 GLY A 65 SITE 2 AC1 5 HIS A 180 SITE 1 AC2 3 ARG A 230 LEU A 255 HOH A 541 SITE 1 AC3 2 ARG A 201 ARG A 230 SITE 1 AC4 9 LYS A 36 TRP A 42 PHE A 43 GLU A 117 SITE 2 AC4 9 HIS A 166 GLU A 195 PHE A 220 SER A 222 SITE 3 AC4 9 HOH A 445 CRYST1 66.240 76.960 113.980 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015097 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012994 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008773 0.00000